{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:42:38Z","timestamp":1789652558708,"version":"4.0.0"},"reference-count":33,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1737,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1111\/j.1365-2893.2010.01400.x","type":"journal-article","created":{"date-parts":[[2010,11,29]],"date-time":"2010-11-29T06:56:21Z","timestamp":1291013781000},"page":"831-839","source":"Crossref","is-referenced-by-count":30,"title":["Minimal transmission of HIV despite persistently high transmission of hepatitis C virus in a Swedish needle exchange program"],"prefix":"10.1111","volume":"18","author":[{"given":"M. Alanko","family":"Blom\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Bj\u00f6rkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Flamholc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Jacobsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Molnegren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Widell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,11,29]]},"reference":[{"key":"10.1111\/j.1365-2893.2010.01400.x-BIB1|cit1","doi-asserted-by":"crossref","unstructured":"WHO Regional Office for Europe and UNAIDS report on progress since the Dublin Declaration Euro Surveill 2008 13","DOI":"10.2807\/ese.13.37.18981-en"},{"key":"10.1111\/j.1365-2893.2010.01400.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","article-title":"Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review","volume":"372","author":"Mathers","year":"2008","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2893.2010.01400.x-BIB3|cit3","unstructured":"WHO Effectiveness of sterile needle and syringe programming in reducing HIV\/AIDS among injecting drug users (evidence for action technical papers) WHO Library Cataloguing-in-Publication Data 2004"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2893.2010.01400.x-BIB4|cit4","first-page":"75","article-title":"The role of needle exchange programs in HIV prevention","volume":"113","author":"Vlahov","year":"1998","journal-title":"Public Health Rep"},{"key":"10.1111\/j.1365-2893.2010.01400.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/jech.2007.064154","article-title":"Associations between HIV-related injection behaviour and distance to and patterns of utilisation of syringe-supply programmes","volume":"62","author":"Bruneau","year":"2008","journal-title":"J Epidemiol Community Health"},{"key":"10.1111\/j.1365-2893.2010.01400.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/jurban\/78.2.340","article-title":"Needle-exchange participation, effectiveness, and policy: syringe relay, gender, and the paradox of public health","volume":"78","author":"Valente","year":"2001","journal-title":"J Urban Health"},{"key":"10.1111\/j.1365-2893.2010.01400.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1477-7517-2-22","article-title":"Effectiveness of harm reduction programmes for injecting drug users in Dhaka city","volume":"2","author":"Azim","year":"2005","journal-title":"Harm Reduct J"},{"key":"10.1111\/j.1365-2893.2010.01400.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1365-2893.2005.00643.x","article-title":"Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis","volume":"12","author":"Judd","year":"2005","journal-title":"J Viral Hepat"},{"issue":"Suppl 8","key":"10.1111\/j.1365-2893.2010.01400.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1097\/01.aids.0000304707.56670.cf","article-title":"An evaluation of needle exchange programmes in China","volume":"21","author":"Liu","year":"2007","journal-title":"AIDS"},{"key":"10.1111\/j.1365-2893.2010.01400.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/QAI.0b013e318050d260","article-title":"Needle exchange and injection-related risk behaviors in Chicago: a longitudinal study","volume":"45","author":"Huo","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1365-2893.2010.01400.x-BIB11|cit11","first-page":"889","article-title":"Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection","volume":"165","author":"Patrick","year":"2001","journal-title":"CMAJ"},{"key":"10.1111\/j.1365-2893.2010.01400.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/j.1360-0443.2006.01543.x","article-title":"Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia","volume":"101","author":"Maher","year":"2006","journal-title":"Addiction"},{"issue":"Suppl 8","key":"10.1111\/j.1365-2893.2010.01400.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1097\/01.aids.0000304695.54884.4f","article-title":"Incidence of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: a 3-year follow-up study","volume":"21","author":"Ruan","year":"2007","journal-title":"AIDS"},{"key":"10.1111\/j.1365-2893.2010.01400.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/00365540050165875","article-title":"Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe\/needle exchange program","volume":"32","author":"M\u00e5nsson","year":"2000","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/j.1365-2893.2010.01400.x-BIB15|cit15","unstructured":"Swedish Institute for Disease Control S Statistics for HIV-infection in Sweden http:\/\/www.smittskyddsinstitutet.se\/statistik\/hivinfektion\/?t=com&p=8752#statistics-nav"},{"key":"10.1111\/j.1365-2893.2010.01400.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1080\/003655200750023246","article-title":"Prevalence and clinical spectrum of chronic viral hepatitis in a middle-aged Swedish general urban population","volume":"35","author":"Hoffmann","year":"2000","journal-title":"Scand J Gastroenterol"},{"issue":"21","key":"10.1111\/j.1365-2893.2010.01400.x-BIB17|cit17","doi-asserted-by":"crossref","DOI":"10.2807\/ese.13.21.18882-en","article-title":"The epidemiology of hepatitis C virus infection in Sweden","volume":"13","author":"Duberg","year":"2008","journal-title":"Euro Surveill"},{"key":"10.1111\/j.1365-2893.2010.01400.x-BIB18|cit18","unstructured":"Regional Centre for Communicable Disease Control S Smittskydd Sk\u00e5ne ,1:6 http:\/\/www.skane.se\/upload\/Webbplatser\/Smittskydd\/Dokument\/2006mars.pdf#page=2"},{"key":"10.1111\/j.1365-2893.2010.01400.x-BIB19|cit19","unstructured":"Federation of alcohol and drug awareness in Sweden C Drug trends in Sweden 2006: report nr 98 2006 http:\/\/www.can.se\/documents\/CAN\/Rapporter\/rapportserie\/CAN-rapportserie-98-drogutvecklingen-i-sverige-2006.pdf"},{"key":"10.1111\/j.1365-2893.2010.01400.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.drugpo.2007.04.004","article-title":"Global estimates of prevalence of HCV infection among injecting drug users","volume":"18","author":"Aceijas","year":"2007","journal-title":"Int J Drug Policy"},{"key":"10.1111\/j.1365-2893.2010.01400.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.drugalcdep.2008.11.007","article-title":"Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City","volume":"101","author":"Des Jarlais","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"10.1111\/j.1365-2893.2010.01400.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1023\/A:1014560431726","article-title":"Measures to reduce HIV infection have not been successful to reduce the prevalence of HCV in intravenous drug users","volume":"17","author":"Hernandez-Aguado","year":"2001","journal-title":"Eur J Epidemiol"},{"key":"10.1111\/j.1365-2893.2010.01400.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"220","DOI":"10.5694\/j.1326-5377.1999.tb140325.x","article-title":"The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not","volume":"170","author":"Crofts","year":"1999","journal-title":"Med J Aust"},{"issue":"Suppl 1","key":"10.1111\/j.1365-2893.2010.01400.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S0376-8716(06)80005-0","article-title":"Significant reductions of HIV prevalence but not of hepatitis C virus infections in injection drug users from metropolitan Barcelona: 1987-2001","volume":"82","author":"Muga","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"10.1111\/j.1365-2893.2010.01400.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/j.1440-1746.2006.04568.x","article-title":"Transmission of hepatitis C virus by needle-stick injury in community settings","volume":"22","author":"Haber","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2893.2010.01400.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1086\/656212","article-title":"Survival of hepatitis C virus in syringes: implication for transmission among injection drug users","volume":"202","author":"Paintsil","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1365-2893.2010.01400.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1477-7517-3-27","article-title":"A review of the evidence for the effectiveness of primary prevention interventions for hepatitis C among injecting drug users","volume":"3","author":"Wright","year":"2006","journal-title":"Harm Reduct J"},{"key":"10.1111\/j.1365-2893.2010.01400.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/j.1360-0443.2007.01912.x","article-title":"Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users","volume":"102","author":"Van Den Berg","year":"2007","journal-title":"Addiction"},{"key":"10.1111\/j.1365-2893.2010.01400.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/01.ede.0000135170.54913.9d","article-title":"Hepatitis C virus infection among injection drug users: survival analysis of time to seroconversion","volume":"15","author":"Hagan","year":"2004","journal-title":"Epidemiology"},{"key":"10.1111\/j.1365-2893.2010.01400.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1365-2893.2005.00640.x","article-title":"Viral evolution of hepatitis C in injection drug users","volume":"12","author":"Dove","year":"2005","journal-title":"J Viral Hepat"},{"key":"10.1111\/j.1365-2893.2010.01400.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.2105\/AJPH.2003.036517","article-title":"HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services","volume":"95","author":"Des Jarlais","year":"2005","journal-title":"Am J Public Health"},{"key":"10.1111\/j.1365-2893.2010.01400.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"F59","DOI":"10.1097\/00002030-199708000-00001","article-title":"Needle exchange is not enough: lessons from the Vancouver injecting drug use study","volume":"11","author":"Strathdee","year":"1997","journal-title":"AIDS"},{"key":"10.1111\/j.1365-2893.2010.01400.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1477-7517-6-5","article-title":"HIV\/AIDS in Vancouver, British Columbia: a growing epidemic","volume":"6","author":"McInnes","year":"2009","journal-title":"Harm Reduct J"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2893.2010.01400.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2893.2010.01400.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T08:42:51Z","timestamp":1625560971000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2893.2010.01400.x"}},"subtitle":["HCV in a needle exchange program"],"short-title":[],"issued":{"date-parts":[[2010,11,29]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2893.2010.01400.x","relation":{},"ISSN":["1352-0504"],"issn-type":[{"value":"1352-0504","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11,29]]}}}